Form 4: STERIS Director Mohsen's Share Transactions

STERIS plc Director Mohsen Sohi reported the exercise of stock options and sale of shares, alongside new grants of equity awards.

Summary

• Director Mohsen Sohi reported transactions involving STERIS plc ordinary shares and derivative securities.
• On August 11, 2025, 4,110 ordinary shares were acquired at an exercise price of $64.05 per share through the exercise of a stock option.
• Concurrently, 4,110 ordinary shares were disposed of at a weighted average sale price of $241.96 per share, with prices ranging from $241.36 to $242.295.
• Following these transactions, the direct beneficial ownership of ordinary shares is 22,361.
• On August 8, 2025, 2,226 nonqualified stock options were acquired with an exercise price of $242.85, which are fully vested and immediately exercisable, expiring on August 8, 2035.
• Also on August 8, 2025, 772 Career Restricted Stock Units (RSUs) were acquired, fully vested immediately, to be settled six months after the cessation of Board service.
• An additional 506 Career Restricted Stock Units were acquired on August 8, 2025, issued in lieu of $123,000 in fees, also fully vested immediately and to be settled six months after the cessation of Board service.
• The option to purchase 4,110 shares at $64.05, which was exercised, was received in connection with STERIS plc's redomiciliation to Ireland in March 2019.

Sentiment

Score: 6

Explanation: The filing reports routine insider transactions, including the exercise of options and sale of shares, alongside new equity grants. The sale is likely for liquidity or tax purposes following option exercise, which is a neutral event. The new grants are positive for the director's long-term alignment with the company.

Positives

• Director Mohsen Sohi received new grants of 2,226 nonqualified stock options and 1,278 Career Restricted Stock Units (772 + 506).
• The newly granted stock options and restricted stock units are fully vested immediately upon grant.
• 506 Career Restricted Stock Units were issued in lieu of $123,000 in fees, indicating compensation through equity and aligning director interests with shareholders.

Negatives

• Director Mohsen Sohi sold 4,110 ordinary shares, reducing direct beneficial ownership from 26,471 to 22,361 shares.

Future Outlook

NA

Industry Context

NA

Stakeholder Impact

• Shareholders: Provides transparency into insider holdings and transactions, which can influence investor sentiment. The sale of shares by a director might be viewed negatively by some, while new equity grants align director interests with shareholders.

Next Steps

• Settlement of Career Restricted Stock Units six months after the cessation of the Director's Board service.

Key Dates

Recommendation

The filing details routine insider transactions, including the exercise of options and subsequent sale of shares, alongside new equity grants. While the sale reduces the director's direct holdings, it appears to be a common 'sell-to-cover' or liquidity event following option exercise, rather than a signal of negative sentiment. The new equity grants align the director's interests with long-term shareholder value. These transactions do not fundamentally alter the company's operational or financial outlook, thus a 'hold' recommendation is appropriate as the filing itself doesn't provide new information warranting a change in investment thesis.

Keywords

STERIS plc, STE, SEC Form 4, Insider Trading, Stock Option Exercise, Share Sale, Restricted Stock Units, Director Compensation, Equity Awards, Beneficial Ownership